Pfiza net profit following the results of the first nine months increased by 28%


American pharmaceutical company Pfiza, one of the world leaders in this industry, from January to September 2018, increased its net profit by 28% in annual terms to 11 billion 546 million dollars, writes, referring to the company's statements. Earnings per share rose to 1 dollar 92 cents from 1 dollar 49 cents a year earlier. Revenue increased by 2% and amounted to 39 billion 700 million dollars. In the third quarter, Pfiza net profit increased 1.5 times, and its revenue increased by 1%. At the same time, in the sector of basic medical goods and services a decrease by 4% was observed.

The information and recommendations contained in this analytical document are published strictly for information purposes and are not considered as an offer to buy or sell the trading tools mentioned above and are not intended to motivate to perform certain transactions
Something went wrong